← Back to Search

Behavioral Intervention

Frequent Hemodialysis Network: Nocturnal Trial

Phase 2 & 3
Waitlist Available
Led By Michael V. Rocco, M.D.
Research Sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

The Frequent Hemodialysis (FHN) Nocturnal Trial is a randomized controlled trial recruiting subjects from dialysis units associated with designated Clinical Centers in the U.S. and Canada and followed for 12 months. Subjects will be randomized to conventional hemodialysis delivered three days per week home arm or to the six times per week nocturnal home hemodialysis arm which will follow any dialysis prescription provided their prescribed standardized Kt/V is at least 4.0 and treatment time is at least 6.0 hours, six times per week.

Eligible Conditions
  • Kidney Failure
  • Hemodialysis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: 2Experimental Treatment1 Intervention
Six times a week nocturnal home hemodialysis
Group II: 1Active Control1 Intervention
Three times a week conventional at home hemodialysis

Find a Location

Who is running the clinical trial?

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Lead Sponsor
2,464 Previous Clinical Trials
4,337,303 Total Patients Enrolled
10 Trials studying Kidney Failure
10,720 Patients Enrolled for Kidney Failure
Michael V. Rocco, M.D.Principal InvestigatorWake Forest University
Gerald J. Beck, Ph.D.Principal InvestigatorThe Cleveland Clinic
1 Previous Clinical Trials
245 Total Patients Enrolled
Paul W. Eggers, Ph.D.Study DirectorNIDDK, NIH
1 Previous Clinical Trials
245 Total Patients Enrolled
Alan S. Kliger, M.D.Study ChairHospital of St. Raphael
1 Previous Clinical Trials
245 Total Patients Enrolled
~7 spots leftby Jan 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top